A new hope with amazing results
Have you met people who have an excessive urge of hand washing, frequent checking to ensure if the door is locked, or changes clothes every time they go to washroom? Understandably, none of these actions are happy works and their repetitive deeds of these activities can be truly challenging for the other people staying together.
Patterns of heritability, clinical phenomenology, and mutual co-morbidity suggest that obsessive-compulsive disorder (OCD) is linked with Tourette’s syndrome (TS). There is still too much left to understand about the pathophysiology of this condition, but the neurophysiological characteristics suggest that the OCD is a brain-based anxiety disorder that causes repeated unwanted thoughts or sensations (obsessions) which might or might not seem logical.
This mental health disorder can affect people from all walks of life and across all ages.
People with OCD generally have thoughts or actions which –
Obsessions are unwanted, invasive thoughts, urges or images that trigger strongly upsetting beliefs and opinions. What separates OCD obsessions from normal obsessions is their intensity, frequency and the discomfort level.
Compulsions are behaviors which these individual take on themselves attempting to eliminate their obsessions and/or decrease his or her distress. These repeated behaviors or thoughts aid these patients in feeling safer. Unfortunately, these compulsive behavior do not actually prove useful instead get in the way of work, and other social obligations.
There are four basic categories into which OCD is classified. They are –
OCD has been classified as one the leading causes of disability worldwide by the World Health Organization.
BrainsWay introduced the First FDA Cleared (De-Novo) Non-invasive Medical Device for the Treatment of OCD.
It is the only FDA approved TMS treatment available when looking for non-medicative and non invasive alternative options. The Brainsway technology and proprietary H7-coil magnective system works by stimulating the frontal lobes of the brain.
Brainsway has shown proven result in treating OCD symptoms. This outpatient procedure does not take any more than 30 minutes and there’s hardly any side effect reported.
The BrainsWay’s Deep-TMS study showed results after six weeks of treatment. It is the only multi-center trial in OCD patients ever conducted and showed significant improvement in the primary endpoint results for the active treatment group when compared to sham (p=0.0127). The primary outcome measure of this study was the OCD Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), which is considered as the gold standard measure of OCD symptom severity.
